The BioIndustry Association (BIA) has today elected Dr John Brown, Paul Drohan, Steven Harris, Dr Ed Hodgkin and Dr Sam Williams to its Board of Directors at its Annual General Meeting. In addition Kate Bingham, Tim Edwards, Dr Jeremy Haigh, Geoff Newman, Ian Nicholson and Peter Nolan have been re-elected. The new Board members will serve from 1 January 2010.
Clive Dix, BIA Chairman, said:
“I would like to welcome our new Board members. I believe they will maintain the strength of the BIA Board and will bring valuable experience on which the BIA can call. I look forward to working with them to help the BIA deliver a strategy to meet our objectives and build on our successes in meeting the needs of our members.
“I would also like to thank the Board members that will step down at the end of the year for their contributions to the BIA.”
ENDS
For further information, please contact Emma Palmer Foster, Interim Head of External Relations, 02… ; or Robert Winder, Communications Manager, 02… or 07… .
Notes to editors
- Kate Bingham is a Managing Partner at SV Life Sciences.
- Dr John Brown is Chairman of BTG plc and CXR Biosciences Ltd and a non-executive Director of Vectura Group plc and Axis-Shield plc.
- Paul Drohan is General Manager and Vice-President of Genzyme UK & Ireland.
- Tim Edwards is President and Chief Executive Officer of Cellzome Inc.
- Dr Jeremy Haigh is Vice President and International Chief Operating Officer, Research & Development, at Amgen.
- Steven Harris is CEO of Circassia Ltd.
- Dr Edward Hodgkin is CEO of Biotica Technology Ltd.
- Geoff Newman is the co-founder and Managing Director of Interea International Ltd.
- Ian Nicholson is Chief Executive Officer of Chroma Therapeutics Ltd.
- Peter Nolan is Executive Director and Senior Vice President, Commercial Development, at Oxford BioMedica plc.
- Dr Sam Williams is Chief Executive Officer of Modern Biosciences plc.
Full biographies of the BIA Board members are available on request.
BioIndustry Association
Established in 1989, the BIA (BioIndustry Association) exists to encourage and promote a financially sound and thriving bioscience sector within the UK economy and concentrates its efforts on emerging enterprise and the related interests of companies with whom such enterprise trades.
With over 300 members, the BIA supports a wide range of sectors, majoring on the human health benefits of the technology and represents the interests of these innovative companies to a broad section of stakeholders from patient groups to politicians, advancing its members interests both within the UK and internationally to create a healthy UK bioscience sector which benefits society. For further information, please go to: www.bioindustry.org
